Epilepsy Trial, Recruiting (NCT07026591)

Epilepsy Trial, Recruiting NCT07026591 Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT07026591 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are between 18 and 65 years old
People who hold a category B driving licence
People who drive at least once a month
People who do not have a medical condition that prevents them from driving, except for epilepsy (people with epilepsy may still be eligible)
People who agree to take part in the study by giving their explicit consent
People who are covered by, or benefit from, a social security scheme

Who may not be able to join:

People who are under certain types of legal protection, such as full guardianship — however, people with epilepsy who are under guardianship or curatorship arrangements are accepted, as this group makes up a significant portion of patients at the trial site
Women who are pregnant or currently breastfeeding
People who are known to experience cybersickness, which is motion sickness or discomfort caused by virtual reality or driving simulators

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 1 48 03 64 54

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07026591

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: +33 1 48 03 64 54

More information: https://clinicaltrials.gov/study/NCT07026591

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are between 18 and 65 years old
People who hold a category B driving licence
People who drive at least once a month
People who do not have a medical condition that prevents them from driving, except for epilepsy (people with epilepsy may still be eligible)
People who agree to take part in the study by giving their explicit consent
People who are covered by, or benefit from, a social security scheme

Who may not be able to join:

People who are under certain types of legal protection, such as full guardianship — however, people with epilepsy who are under guardianship or curatorship arrangements are accepted, as this group makes up a significant portion of patients at the trial site
Women who are pregnant or currently breastfeeding
People who are known to experience cybersickness, which is motion sickness or discomfort caused by virtual reality or driving simulators

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Registry

ClinicalTrials.gov

Start date

6 November 2025

Est. completion

1 November 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Speed; Phasic alertness; Lane position; Braking time; Information processing time; Sustained attention; Divided attention; Visual scanning

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov